Dendritic cell function in cytomegalovirus-infected patients with mononucleosis

Journal of Leukocyte Biology

Volumn 79, Issue 5, 2006, Pages 932-940

  Frascaroli, Giada ^b,c   Varani, Stefania ^a,b   Mastroianni, Antonio ^d   Britton, Sven ^a   Gibellini, Davide ^b   Rossini, Giada ^b   Landini, Maria P ^b   Söderberg Nauclér, Cecilia ^a,e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF ULM   (Germany)

^d MORGAGNI PIERANTONI HOSPITAL   (Italy)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antigen presenting cells; Viral infection; Viral induced immunomodulation

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; CHEMOKINE; CYTOKINE; HISTOCOMPATIBILITY ANTIGEN; IMMUNOLOGIC FACTOR; VIRUS PROTEIN;

ADULT; ANTIGEN PRESENTING CELL; ARTICLE; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; MALE; MIXED LYMPHOCYTE REACTION; MONOCYTE; MONONUCLEOSIS; PINOCYTOSIS; PRIORITY JOURNAL; VIRUS INFECTION; CELL CULTURE; CELLULAR IMMUNITY; CYTOMEGALIC INCLUSION BODY DISEASE; DOWN REGULATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INFECTIOUS MONONUCLEOSIS; MIDDLE AGED; NEUTROPHIL CHEMOTAXIS; SECRETION; VIROLOGY;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

ADULT; CELLS, CULTURED; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DENDRITIC CELLS; DOWN-REGULATION; FEMALE; HISTOCOMPATIBILITY ANTIGENS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; IMMUNOLOGIC FACTORS; IMMUNOPHENOTYPING; INFECTIOUS MONONUCLEOSIS; MALE; MIDDLE AGED; PINOCYTOSIS; VIRAL PROTEINS;

EID: 33745321372     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0905499     Document Type: Article

References (48)

1. Pass, R. (2001) Cytomegalovirus. In Fields Virology, Vol. 2 (D. Knipe, P. Howley, eds.), Philadelphia, PA, Lippincott Williams and Wilkins, 2675-2705.
2. Griffin, D. (1996) Potential mechanisms of immune suppression. In Viral Pathogenesis (N. Nathanson, ed.), Philadelphia, PA, Lippincott-Raven, 207-235.
3. Nichols, W. G., Corey, L., Gooley, T., Davis, C., Boeckh, M. (2002) High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection. J. Infect. Dis. 185, 273-282.
4. George, M. J., Snydman, D. R., Werner, B. G., Griffith, J., Falagas, M. E., Dougherty, N. N., Rubin, R. H. (1997) The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc., Gaithersburg, Maryland. Am. J. Med. 103, 106-113.
5. Rinaldo Jr., C. R., Carney, W. P., Richter, B. S., Black, P. H., Hirsch, M. S. (1980) Mechanisms of immunosuppression in cytomegaloviral mononucleosis. J. Infect. Dis. 141, 488-495.
6. Levin, M. J., Rinaldo Jr., C. R., Leary, P. L., Zaia, J. A., Hirsch, M. S. (1979) Immune response to herpesvirus antigens in adults with acute cytomegaloviral mononucleosis. J. Infect. Dis. 140, 851-857.
7. Schrier, R. D., Rice, G. P., Oldstone, M. B. (1986) Suppression of natural killer cell activity and T cell proliferation by fresh isolates of human cytomegalovirus. J. Infect. Dis. 153, 1084-1091.
8. Simmons, P., Kaushansky, K., Torok-Storb, B. (1990) Mechanisms of cytomegalovirus-mediated myelosuppression: perturbation of stromal cell function versus direct infection of myeloid cells. Proc. Natl. Acad. Sci. USA 87, 1386-1390.
9. Torok-Storb, B., Simmons, P., Khaira, D., Stachel, D., Myerson, D. (1992) Cytomegalovirus and marrow function. Ann. Hematol. 64 (Suppl.), A128-A131.
10. Michelson, S. (2004) Consequences of human cytomegalovirus mimicry. Hum. Immunol. 65, 465-475.
11. Loenen, W. A., Bruggeman, C. A., Wiertz, E. J. (2001) Immune evasion by human cytomegalovirus: lessons in immunology and cell biology. Semin. Immunol. 13, 41-49.
12. Spencer, J. V., Lockridge, K. M., Barry, P. A., Lin, G., Tsang, M., Penfold, M. E., Schall, T. J. (2002) Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J. Virol. 76, 1285-1292.
13. Gredmark, S., Soderberg-Naucler, C. (2003) Human cytomegalovirus inhibits differentiation of monocytes into dendritic cells with the consequence of depressed immunological functions. J. Virol. 77, 10943-10956.
14. Moutaftsi, M., Mehl, A. M., Borysiewicz, L. K., Tabi, Z. (2002) Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells. Blood 99, 2913-2921.
15. Beck, K., Meyer-Konig, U., Weidmann, M., Nern, C., Hufert, F. T. (2003) Human cytomegalovirus impairs dendritic cell function: a novel mechanism of human cytomegalovirus immune escape. Eur. J. Immunol. 33, 1528-1538.
16. Varani, S., Frascaroli, G., Homman-Loudiyi, M., Feld, S., Landini, M. P., Soderberg-Naucler, C. (2005) Human cytomegalovirus inhibits the migration of immature dendritic cells by down-regulating cell-surface CCR1 and CCR5. J. Leukoc. Biol. 77, 219-228.
17. Moutaftsi, M., Brennan, P., Spector, S. A., Tabi, Z. (2004) Impaired lymphoid chemokine-mediated migration due to a block on the chemokine receptor switch in human cytomegalovirus-infected dendritic cells. J. Virol. 78, 3046-3054.
18. Grigoleit, U., Riegler, S., Einsele, H., Laib Sampaio, K., Jahn, G., Hebart, H., Brossart, P., Frank, F., Sinzger, C. (2002) Human cytomegalovirus induces a direct inhibitory effect on antigen presentation by monocyte-derived immature dendritic cells. Br. J. Haematol. 119, 189-198.
19. Chang, W. L., Baumgarth, N., Yu, D., Barry, P. A. (2004) Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality. J. Virol. 78, 8720-8731.
20. Raftery, M. J., Wieland, D., Gronewald, S., Kraus, A. A., Giese, T., Schonrich, G. (2004) Shaping phenotype, function, and survival of dendritic cells by cytomegalovirus-encoded IL-10. J. Immunol. 173, 3383-3391.
21. Varani, S., Frascaroli, G., Gibellini, D., Potena, L., Lazzarotto, T., Lemoli, R. M., Magelli, C., Soderberg-Naucler, C., Landini, M. P. (2005) Impaired dendritic cell immunophenotype and function in heart transplant patients undergoing active cytomegalovirus infection. Transplantation 79, 219-227.
22. Horwitz, C. A., Henle, W., Henle, G., Polesky, H., Balfour Jr., H. H., Siem, R. A., Borken, S., Ward, P. C. (1977) Heterophil-negative infectious mononucleosis and mononucleosis-like illnesses. Laboratory confirmation of 43 cases. Am. J. Med. 63, 947-957.
23. Horwitz, C. A., Henle, W., Henle, G. (1979) Diagnostic aspects of the cytomegalovirus mononucleosis syndrome in previously healthy persons. Postgrad. Med. 66, 153-158.
24. Taylor, G. H. (2003) Cytomegalovirus. Am. Fam. Physician 67, 519-524.
25. Just-Nubling, G., Korn, S., Ludwig, B., Stephan, C., Doerr, H. W., Preiser, W. (2003) Primary cytomegalovirus infection in an outpatient setting - laboratory markers and clinical aspects. Infection 31, 318-323.
26. Wreghitt, T. G., Teare, E. L., Sule, O., Devi, R., Rice, P. (2003) Cytomegalovirus infection in immunocompetent patients. Clin. Infect. Dis. 37, 1603-1606.
27. Gandhi, M. K., Khanna, R. (2004) Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect. Dis. 4, 725-738.
28. Maine, G. T., Stricker, R., Schuler, M., Spesard, J., Brojanac, S., Iriarte, B., Herwig, K., Gramins, T., Combs, B., Wise, J., Simmons, H., Gram, T., Lonze, J., Ruzicki, D., Byrne, B., Clifton, J. D., Chovan, L. E., Wachta, D., Holas, C., Wang, D., Wilson, T., Tomazic-Allen, S., Clements, M. A., Wright Jr., G. L., Lazzarotto, T., Ripalti, A., Landini, M. P. (2000) Development and clinical evaluation of a recombinant-antigen-based cytomegalovirus immunoglobulin M automated immunoassay using the Abbott AxSYM analyzer. J. Clin. Microbiol. 38, 1476-1481.
29. Sallusto, F., Lanzavecchia, A. (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179, 1109-1118.
30. Ratta, M., Rondelli, D., Fortuna, A., Curti, A., Fogli, M., Fagnoni, F., Martinelli, G., Terragna, C., Tura, S., Lemoli, R. M. (1998) Generation and functional characterization of human dendritic cells derived from CD34 cells mobilized into peripheral blood: comparison with bone marrow CD34+ cells. Br. J. Haematol. 101, 756-765.
31. Duperrier, K., Farre, A., Bienvenu, J., Bleyzac, N., Bernaud, J., Gebuhrer, L., Rigal, D., Eljaafari, A. (2002) Cyclosporin A inhibits dendritic cell maturation promoted by TNF-α or LPS but not by double-stranded RNA or CD40L. J. Leukoc. Biol. 72, 953-961.
32. Matyszak, M. K., Citterio, S., Rescigno, M., Ricciardi-Castagnoli, P. (2000) Differential effects of corticosteroids during different stages of dendritic cell maturation. Eur. J. Immunol. 30, 1233-1242.
33. Zanghellini, F., Boppana, S. B., Emery, V. C., Griffiths, P. D., Pass, R. F. (1999) Asymptomatic primary cytomegalovirus infection: virologic and immunologic features. J. Infect. Dis. 180, 702-707.
34. Senechal, B., Boruchov, A. M., Reagan, J. L., Hart, D. N., Young, J. W. (2004) Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83. Blood 103, 4207-4215.
35. Macedo, C., Popescu, I., Abu-Elmagd, K., Reyes, J., Shapiro, R., Zeevi, A., Berghaus, J. M., Wang, L. F., Lu, L., Thomson, A. W., Storkus, W. J., Fung, J. J., Metes, D. (2005) Augmentation of type-1 polarizing ability of monocyte-derived dendritic cells from chronically immunosuppressed organ-transplant recipients. Transplantation 79, 451-459.
36. Langenkamp, A., Messi, M., Lanzavecchia, A., Sallusto, F. (2000) Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat. Immunol. 1, 311-316.
37. Johnson, D. C., Hegde, N. R. (2002) Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus. Curr. Top. Microbiol. Immunol. 269, 101-115.
38. Baillie, J., Sahlender, D. A., Sinclair, J. H. (2003) Human cytomegalovirus infection inhibits tumor necrosis factor α (TNF-α) signaling by targeting the 55-kilodalton TNF-α receptor. J. Virol. 77, 7007-7016.
39. Soderberg-Naucler, C., Fish, K. N., Nelson, J. A. (1997) Interferon-γ and tumor necrosis factor-α specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines. J. Clin. Invest. 100, 3154-3163.
40. Nokta, M. A., Hassan, M. I., Loesch, K., Pollard, R. B. (1996) Human cytomegalovirus-induced immunosuppression. Relationship to tumor necrosis factor-dependent release of arachidonic acid and prostaglandin E2 in human monocytes. J. Clin. Invest. 97, 2635-2641.
41. Humar, A., St Louis, P., Mazzulli, T., McGeer, A., Lipton, J., Messner, H., MacDonald, K. S. (1999) Elevated serum cytokines are associated with cytomegalovirus infection and disease in bone marrow transplant recipients. J. Infect. Dis. 179, 484-488.
42. Tong, C. Y., Bakran, A., Williams, H., Cuevas, L. E., Peiris, J. S., Hart, C. A. (2001) Association of tumor necrosis factor α and interleukin 6 levels with cytomegalovirus DNA detection and disease after renal transplantation. J. Med. Virol. 64, 29-34.
43. Nordoy, I., Muller, F., Nordal, K. P., Rollag, H., Lien, E., Aukrust, P., Froland, S. S. (2000) The role of the tumor necrosis factor system and interleukin-10 during cytomegalovirus infection in renal transplant recipients. J. Infect. Dis. 181, 51-57.
44. Glass, W. G., Rosenberg, H. F., Murphy, P. M. (2003) Chemokine regulation of inflammation during acute viral infection. Curr. Opin. Allergy Clin. Immunol. 3, 467-473.
45. Melchjorsen, J., Sorensen, L. N., Paludan, S. R. (2003) Expression and function of chemokines during viral infections: from molecular mechanisms to in vivo function. J. Leukoc. Biol. 74, 331-343.
46. Saederup, N., Aguirre, S. A., Sparer, T. E., Bouley, D. M., Mocarski, E. S. (2001) Murine cytomegalovirus CC chemokine homolog MCK-2 (m131-129) is a determinant of dissemination that increases inflammation at initial sites of infection. J. Virol. 75, 9966-9976.
47. Penfold, M. E., Dairaghi, D. J., Duke, G. M., Saederup, N., Mocarski, E. S., Kemble, G. W., Schall, T. J. (1999) Cytomegalovirus encodes a potent α chemokine. Proc. Natl. Acad. Sci. USA 96, 9839-9844.
48. Sozzani, S., Allavena, P., Vecchi, A., Mantovani, A. (1999) The role of chemokines in the regulation of dendritic cell trafficking. J. Leukoc. Biol. 66, 1-9.